Revenue, 2024
USD 2.27 Bn
Forecast Year, 2034
USD 4.19 Bn
CAGR, 2025 - 2034
6.32%
Report Coverage
Worldwide
The global enzyme-linked immunosorbent assay (ELISA) testing market reached USD 2.27 billion in 2024 and is expected to climb to USD 4.19 billion by 2034, growing at a 6.32% CAGR, driven by rising diagnostic demand and expanding clinical applications.
Enzyme-Linked Immunosorbent Assay Testing Market Size Analysis
Enzyme-Linked Immunosorbent Assay Testing Market Size By Test Type 2024 to 2034 (USD Billion)
| Test Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandwich ELISA | 0.79 | 0.85 | 0.91 | 0.97 | 1.04 | 1.11 | 1.19 | 1.27 | 1.36 | 1.45 | 1.55 |
| Indirect ELISA | 0.45 | 0.48 | 0.51 | 0.54 | 0.57 | 0.60 | 0.64 | 0.67 | 0.71 | 0.75 | 0.80 |
| Multiple and Portable ELISA | 0.34 | 0.37 | 0.39 | 0.42 | 0.45 | 0.49 | 0.52 | 0.56 | 0.60 | 0.64 | 0.69 |
| Competitive ELISA | 0.41 | 0.43 | 0.46 | 0.49 | 0.52 | 0.55 | 0.58 | 0.62 | 0.65 | 0.69 | 0.73 |
| Others | 0.27 | 0.28 | 0.30 | 0.31 | 0.32 | 0.34 | 0.35 | 0.37 | 0.39 | 0.40 | 0.42 |
Enzyme-Linked Immunosorbent Assay Testing Market Size By Application 2024 to 2034 (USD Billion)
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunology | 0.57 | 0.60 | 0.64 | 0.67 | 0.71 | 0.76 | 0.80 | 0.85 | 0.90 | 0.95 | 1.01 |
| Inflammation | 0.34 | 0.36 | 0.38 | 0.41 | 0.43 | 0.45 | 0.48 | 0.51 | 0.54 | 0.57 | 0.61 |
| Infectious diseases | 0.45 | 0.49 | 0.53 | 0.58 | 0.63 | 0.68 | 0.73 | 0.79 | 0.86 | 0.93 | 1.01 |
| Cancer | 0.41 | 0.44 | 0.47 | 0.51 | 0.55 | 0.59 | 0.63 | 0.68 | 0.73 | 0.78 | 0.84 |
| Protein quantification | 0.27 | 0.28 | 0.30 | 0.31 | 0.32 | 0.34 | 0.35 | 0.37 | 0.39 | 0.40 | 0.42 |
| Other Applications | 0.23 | 0.24 | 0.24 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 | 0.30 | 0.31 | 0.31 |
Enzyme-Linked Immunosorbent Assay Testing Market Size By Region 2024 to 2034 (USD Billion)
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 0.91 | 0.96 | 1.01 | 1.07 | 1.13 | 1.19 | 1.25 | 1.32 | 1.39 | 1.47 | 1.55 |
| Asia Pacific | 0.68 | 0.74 | 0.80 | 0.86 | 0.93 | 1.00 | 1.08 | 1.17 | 1.26 | 1.36 | 1.47 |
| Europe | 0.45 | 0.48 | 0.51 | 0.54 | 0.57 | 0.60 | 0.64 | 0.67 | 0.71 | 0.75 | 0.80 |
| LAMEA | 0.23 | 0.24 | 0.25 | 0.26 | 0.28 | 0.29 | 0.31 | 0.32 | 0.34 | 0.36 | 0.38 |
Enzyme-Linked Immunosorbent Assay Testing Market Size to Attain USD 4.19 Billion by 2034
The enzyme-linked immunosorbent assay testing market size accounted for USD 2.27 billion in 2024 and is predicted to touch around USD 4.19 billion by 2034 at a CAGR of 6.32%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com